Hall H, Jewett M, Landeck N, Nilsson N, Schagerlöf U, Leanza G, et al. Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors. PLoS ONE. 2013;8:e64844 pubmed publisher

Brekk O, Korecka J, Crapart C, Huebecker M, MacBain Z, Rosenthal S, et al. Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity. Acta Neuropathol Commun. 2020;8:127 pubmed publisher

Mazzocchi M, Wyatt S, Mercatelli D, Morari M, Morales Prieto N, Collins L, et al. Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling. Front Cell Dev Biol. 2019;7:191 pubmed publisher

Rusconi R, Ulusoy A, Aboutalebi H, Di Monte D. Long-lasting pathological consequences of overexpression-induced α-synuclein spreading in the rat brain. Aging Cell. 2018;17: pubmed publisher

Rockenstein E, Ostroff G, Dikengil F, Rus F, Mante M, Florio J, et al. Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies. J Neurosci. 2018;38:1000-1014 pubmed publisher

Thakur P, Breger L, Lundblad M, Wan O, Mattsson B, Luk K, et al. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Proc Natl Acad Sci U S A. 2017;114:E8284-E8293 pubmed publisher

Davtyan H, Zagorski K, Petrushina I, Kazarian K, Goldberg N, Petrosyan J, et al. MultiTEP platform-based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency. Neurobiol Aging. 2017;59:156-170 pubmed publisher

Turriani E, Lázaro D, Ryazanov S, Leonov A, Giese A, Schön M, et al. Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death. Proc Natl Acad Sci U S A. 2017;114:E4971-E4977 pubmed publisher

Spencer B, Valera E, Rockenstein E, OVERK C, Mante M, Adame A, et al. Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy. Acta Neuropathol Commun. 2017;5:7 pubmed publisher

Ulusoy A, Musgrove R, Rusconi R, Klinkenberg M, Helwig M, Schneider A, et al. Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury. Acta Neuropathol Commun. 2015;3:13 pubmed publisher

Ulusoy A, Rusconi R, Pérez Revuelta B, Musgrove R, Helwig M, Winzen Reichert B, et al. Caudo-rostral brain spreading of ?-synuclein through vagal connections. EMBO Mol Med. 2013;5:1119-27 pubmed publisher

Béraud D, Hathaway H, Trecki J, Chasovskikh S, Johnson D, Johnson J, et al. Microglial activation and antioxidant responses induced by the Parkinson's disease protein ?-synuclein. J Neuroimmune Pharmacol. 2013;8:94-117 pubmed publisher